Sprionaloctone
NHS England has published this Preliminary Market Engagement Notice for the Licence variation: spironolactone for acne in women.
It is anticipated that there will be two separate contracts to deliver this, as outlined below. • Contract A: Prepare an application for a major (type II) MHRA Marketing Authorisation variation for spironolactone. • Contract B: Submit the pre-prepared application to the MHRA.
Only current Marketing Authorisation Holders of spironolactone are eligible to bid for contract B.
To register an interest in responding to this market engagement exercise and obtain a copy of the Request for Information documentation please go to: http://health.atamis.co.uk.
All communications and Request for Information submissions will be conducted via Atamis.
What the supplier must deliver
It is anticipated that there will
It is anticipated that there will be two separate contracts to deliver this, as outlined below.
Derived from the notice text — always confirm against the original documents.
Make the case to bid
Reveal who to approach at NHS England, Leeds, and generate a go-to-market strategy from their news, accounts and people.
The full intelligence dossier
Our agent reads NHS England, Leeds’s accounts, hunts live signals, finds the people who decide — and hands you a bid strategy plus a go-to-market influence plan, including what your team should post this week. You approve every paid step.
Ask me about this tender, the buyer, who wins their work, or whether you should bid.
- OCID
- ocds-h6vhtk-04e834
- Stage
- planning · Planning
- Source
- Find a Tender
- Buyer ref
- 007330-2025
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Health & Social Care
NHS England, Leeds’s tender network
Assembling the network…